Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

GSK

Company Type: Therapeutics

Main focus: Development of new therapies for infectious diseases, HIV, respiratory/immunology and oncology

Company stage: Clinical

Diseases: Infectious diseases, HIV, respiratory/immunology and oncology

Genome-editing tool: CRISPR-Cas9, RNA editing

Funding stage: IPO (GSK)

Location: Brentford, UK

Website: https://www.gsk.com/en-gb/

Pipeline: https://www.gsk.com/en-gb/innovation/pipeline/

Partners: Wave Life Sciences, University of California (Jennifer Doudna)

GSK is a global biopharma company with a goal to unite science, technology and talent to advance novel therapies. The company seeks innovation in vaccines and specialty medicines to prevent and treat disease.

Tags

HashtagGSK

close
Search CRISPR Medicine